Is irradiation of the supraclavicular and internal mammary lymph nodes now considered the standard of care in women with node positive breast cancer?
In other words, have the results of the MA.20 and EORTC trials changed your practice?
Answer from: Radiation Oncologist at Academic Institution
I hope that this question can be answered more definitively in the near future. At the present time, I await publication (and untimately more maturity) of the MA-20 data set as well as data from EORTC 22922 trial. I read that 10 year data from the EORTC trial will be presented in Europe at the end o...